Package 70518-1196-1

{"route": ["ORAL"], "spl_id": "48c0b1e2-203a-d7b2-e063-6394a90a1035", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199889"], "spl_set_id": ["44095c2b-2e90-45d2-ab45-d0961c41550d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 BOX (70518-1196-1)  / 1 TABLET in 1 POUCH (70518-1196-2)", "package_ndc": "70518-1196-1", "marketing_start_date": "20191022"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (70518-1196-5)", "package_ndc": "70518-1196-5", "marketing_start_date": "20250513"}], "brand_name": "Topiramate", "product_id": "70518-1196_48c0b1e2-203a-d7b2-e063-6394a90a1035", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-1196", "generic_name": "Topiramate", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20180515", "listing_expiration_date": "20271231"}